Clinical trial site and sponsor engagement: Ongoing trend impacts & communication strategies.

Clinical trial sponsor and site engagement communication pathways lay the foundation for study performance and data outcomes. In this insight, Blair Sirockman, Account Manager, Clinical Trials Optimization, highlights how while sites and sponsor share goals of patient recruitment, retention, key milestones, and outcomes, new ways of engagement, site management processes, and AI technologies are reshaping objectives, ambitions, and workflows.

Establish site capacity & infrastructure

In today’s clinical trial management systems, there are many areas recently identified as crucial in changing and streamlining with more modern technologies, as most influenced by AI and the everchanging medical landscape. However, first and foremost, sponsor must simplify workflows, processes and direct engagements with each site, as this has always been priority for a successful and efficient trial performance. By utilizing strong communication pathways and plans, clinical trial sponsor can establish and maintain patient recruitment goals, consistently invest in relationships with site teams. With the help of new AI-tools, there are ways to reduce time spent on administrative and study start up tasks for the site team. With more time available, sites can now turn their attention fully on data collection and enrollment management, executing on the most important actions of trial lifecycle. By using AI-tools to clinical trial sponsor and site communication advantage, it allows more energy focused on patient care, quality trial data, and the overall management health of the study.

Always consider Real-world insights & data strategy

By establishing strong communication patterns between clinical trial sponsor and sites, organic insights and talking points become catalysts for higher quality trial data. In these pathways, there are several different avenues for communications, discussions, regular status updates, and new AI-tools implementations which aid in the overall engagement management. While in constant communications through appropriate cadence and structure, it allows sponsor and site to pivot quicker with protocol amendments and ICF through observational and raw data, or Real-world insights (RWI). In prioritizing a ‘site-first’ approach from sponsor, this allows the clinical trial site medical team to be consistently supported in management throughout all study milestones resulting in more detailed understanding of patient behaviors, trends, and overall trial strategy.

Clinical trial sponsor and site engagement is shifting within the conformity of new proficient technologies and AI-driven solutions. While keeping patient care, compliance, and security at the forefront of all strategies and engagements, there is clear ways in which traditional communications are evolving to adapt with the faster pace change across all human experience. Ensuring there are trial sponsor and site engagement plans, AI-strategies, communication pathways, and flexible approach to the complete trial lifecycle will be the best foundation for clinical trial performance, patient-centric outcomes, and data for our future of science, healthcare and medical solutions.

If you have questions, comments or would like more information on how clinical trial sponsors and site engagements and strategies can be most effectively planned and executed, please reach out to our Clinical Trial Optimization team at [email protected].